Global Cancer Immunotherapy Market Size, Share, Growth, Trends, and Forecast (2024 - 2031)
Global Cancer Immunotherapy Market Scope: Historical Data (2021 – 2022), Base Year (2023), Forecast Period (2024 – 2031)
Market Segmentation: By Product (Monoclonal Antibodies, Immunomodulators, and Oncolytic Viral Therapies and Cancer Vaccines), Application (Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma, Prostate Cancer, Head and Neck Cancer, Ovarian Cancer, Pancreatic Cancer, and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)
Market Overview
The Global Cancer Immunotherapy Market was valued at USD 139,008.7 million in 2023 and is expected to reach USD 270,943.3 million by 2031 while growing at a CAGR of 8.7% during the forecast period (2024-2031).
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Market Dynamics
This section of the report will analyze various driving and restraining factors that are expected to have a significant impact on the global cancer immunotherapy market growth. Immunotherapy, a treatment modality, leverages the body's immune system to identify, target, and eliminate cancer cells, in contrast to conventional methods such as chemotherapy and radiation therapy that directly attack cancer cells.
The rising prevalence of cancer, coupled with increased investments in biotechnology companies and research institutions, drives the cancer immunotherapy market. Nonetheless, the market growth is hampered by high development costs and challenges posed by tumor heterogeneity and resistance.
Furthermore, the global cancer immunotherapy industry will be analyzed through various tools including PESTLE analysis, and Porter’s analysis.
Segmentation – By Product Analysis
The Global Cancer Immunotherapy Market is segmented among Monoclonal Antibodies, Immunomodulators, and Oncolytic Viral Therapies and Cancer Vaccines, based on Product. In 2023, Monoclonal Antibodies accounted for the majority of the market share*.
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Segmentation – By Application Analysis
The Global Cancer Immunotherapy Market is segmented among Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma, Prostate Cancer, Head and Neck Cancer, Ovarian Cancer, Pancreatic Cancer, and Others, based on Application. In 2023, Lung Cancer accounted for the majority of the market share*.
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Global Cancer Immunotherapy Market: Regional Analysis
Based on region, the market is divided into six regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. In 2023, North America dominated the market with the highest market share, while Asia Pacific is expected to grow with the highest CAGR during the forecast period (2024 – 2031).
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Competitive Landscape
Some of the key players operating in the market are Pfizer Inc., AstraZeneca, Merck & Co., Inc, F. Hoffmann-La Roche Ltd, Bristol-Myers Squibb Company, Novartis AG, Eli Lilly, Johnson & Johnson Services, Inc, and Immunocore, Ltd
Table of Contents:
1. Research Methodology and Market Scope
Research Methodology
Market Scope
2. Executive Summary
3. Global Cancer Immunotherapy Market Dynamics
Drivers
Restraints
Opportunity
4. Global Cancer Immunotherapy Industry Analysis
PEST Analysis
Porter's Five Force Analysis
Recent Deals Analysis
5. Global Cancer Immunotherapy Market Segmentation, By Product
Global Cancer Immunotherapy Market Share Analysis, By Product
Global Cancer Immunotherapy Market Growth Analysis, By Product
Global Cancer Immunotherapy Market Trends, By Product
o Monoclonal Antibodies
o Immunomodulators
o Oncolytic Viral Therapies and Cancer Vaccines
6. Global Cancer Immunotherapy Market Segmentation, By Application
Global Cancer Immunotherapy Market Share Analysis, By Application
Global Cancer Immunotherapy Market Growth Analysis, By Application
Global Cancer Immunotherapy Market Trends, By Application
o Lung Cancer
o Breast Cancer
o Colorectal Cancer
o Melanoma
o Prostate Cancer
o Head and Neck Cancer
o Ovarian Cancer
o Pancreatic Cancer
o Others
7. Global Cancer Immunotherapy Market Segmentation, By Distribution Channel
Global Cancer Immunotherapy Market Share Analysis, By Distribution Channel
Global Cancer Immunotherapy Market Growth Analysis, By Distribution Channel
Global Cancer Immunotherapy Market Trends, By Distribution Channel
o Hospital Pharmacy
o Retail Pharmacy
o Online Pharmacy
8. Global Cancer Immunotherapy Market Segmentation, By Region
Global Cancer Immunotherapy Market Share Analysis, By Region
Global Cancer Immunotherapy Market Growth Analysis, By Region
Global Cancer Immunotherapy Market Trends, By Region
o North America
o Europe
o Asia Pacific
o Latin America
o Middle East
o Africa
9. Competitive Landscape
Pfizer Inc.*
o Company Overview
o Financial Performance
o Key Development/Strategies
o SWOT Analysis
AstraZeneca
Merck & Co., Inc
F. Hoffmann-La Roche Ltd
Bristol-Myers Squibb Company
Novartis AG
Lilly
Johnson & Johnson Services, Inc
Immunocore, Ltd
*Similar analysis will be provided for each company listed above.
